| 1 |
[GO] |
Intrinsic Activity |
2024―Aug―29 |
Nirmatrelvir-ritonavir and molnupiravir for the outpatient treatment of Covid-19: a population-based cohort study |
Anselm Jorda |
| 2 |
[GO] |
Intrinsic Activity |
2023―Sep―20 |
Suicidality and drug self-poisoning during the COVID-19 pandemic |
Kelečević Igor |
| 3 |
[GO] |
Intrinsic Activity |
2022―Aug―23 |
Effect of a previous COVID-19 infection on the retinal vasculature |
Theresa Lindner |
| 4 |
[GO] |
Intrinsic Activity |
2022―Aug―23 |
The impact of the COVID-19 pandemic on the consumption of anxiolytic drugs in Serbia: an analysis for the period 2019 - 2021 |
Janko Samardžić |
| 5 |
[GO] |
Intrinsic Activity |
2021―Nov―29 |
Stellungnahme der Österreichischen Pharmakologischen Gesellschaft (APHAR) zu gefährlichen Falschinformationen über die Behandlung der Coronavirus-Infektion COVID-19 |
Thomas Griesbacher, Jörg Striessnig, Alexandra Koschak, Michael Pohl, Eva Maria Zebedin-Brandl, Romuald Bellmann, et al. (+3) Markus Zeitlinger, Martin Brunner, Johannes Pleiner-Duxneuner |
| 6 |
[GO] |
Intrinsic Activity |
2021―Nov―28 |
Stellungnahme der Österreichischen Pharmakologischen Gesellschaft (APHAR) zu gefährlichen Falschinformationen über die Behandlung der Coronavirus-Infektion COVID-19 |
Thomas Griesbacher, Jörg Striessnig, Alexandra Koschak, Michael Pohl, Eva Maria Zebedin-Brandl, Romuald Bellmann, et al. (+3) Markus Zeitlinger, Martin Brunner, Johannes Pleiner-Duxneuner |
